dc.creatorANDRADEMENA, CE
dc.date.accessioned2015-11-19T18:56:31Z
dc.date.accessioned2022-11-02T16:11:34Z
dc.date.available2015-11-19T18:56:31Z
dc.date.available2022-11-02T16:11:34Z
dc.date.created2015-11-19T18:56:31Z
dc.date.issued1989
dc.identifier0165-5728
dc.identifierhttp://hdl.handle.net/20.500.12104/69664
dc.identifier10.1016/0165-5728(89)90008-8
dc.identifierhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med3&AN=2563736
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5021323
dc.languageEnglish
dc.publisherELSEVIER SCIENCE BV
dc.relationJOURNAL OF NEUROIMMUNOLOGY
dc.relation22
dc.relation1
dc.relation47
dc.relation53
dc.relationWOS
dc.relationMEDLINE
dc.titleINHIBITION OF LIPOPOLYSACCHARIDE-INDUCED ALPHA-BETA-INTERFERON SYNTHESIS BY DOPAMINE AND THE DOPAMINE-1 AGONIST FENOLDOPAM
dc.typeArticle


Este ítem pertenece a la siguiente institución